{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:19:46Z","timestamp":1780564786442,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.arth.2026.02.049","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:49:43Z","timestamp":1773272983000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is Low-Dose Aspirin the Safest Prophylaxis for Venous Thromboembolism Following Primary Total Hip Arthroplasty?"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8090-4575","authenticated-orcid":false,"given":"Sri","family":"Tummala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruni S.","family":"Areti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yida","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia F.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil N.","family":"Sambandam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2026.02.049_bib1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamainternmed.2019.6108","article-title":"Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials","volume":"180","author":"Matharu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.arth.2026.02.049_bib2","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0140-6736(07)60457-7","article-title":"The operation of the century: total hip replacement","volume":"370","author":"Learmonth","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.arth.2026.02.049_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(00)05249-1","article-title":"Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials","volume":"358","author":"Eikelboom","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.arth.2026.02.049_bib5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2106\/JBJS.16.01253","article-title":"Venous thromboembolism following hip and knee arthroplasty: the role of aspirin","volume":"99","author":"Parvizi","year":"2017","journal-title":"J Bone Jt Surg Am"},{"key":"10.1016\/j.arth.2026.02.049_bib6","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2106\/JBJS.23.01158","article-title":"Low-dose aspirin is the safest prophylaxis for prevention of venous thromboembolism after total knee arthroplasty across all patient risk profiles","volume":"106","author":"Lavu","year":"2024","journal-title":"J Bone Jt Surg Am"},{"issue":"Suppl 1","key":"10.1016\/j.arth.2026.02.049_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2106\/JBJS.21.01529","article-title":"Recommendations from the ICM-VTE: hip & knee","volume":"104","year":"2022","journal-title":"J Bone Jt Surg Am"},{"key":"10.1016\/j.arth.2026.02.049_bib8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jama.301.10.1063","article-title":"The CMS ruling on venous thromboembolism after total knee or hip arthroplasty: weighing risks and benefits","volume":"301","author":"Streiff","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.arth.2026.02.049_bib9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0883-5403(97)90131-5","article-title":"Incidence of fatal pulmonary embolism after 1,390 knee arthroplasties without routine prophylactic anticoagulation, except in high-risk cases","volume":"12","author":"Ansari","year":"1997","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2026.02.049_bib10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/medicina56090416","article-title":"An update on venous thromboembolism rates and prophylaxis in hip and knee arthroplasty in 2020","volume":"56","author":"Santana","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.arth.2026.02.049_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.surge.2019.11.002","article-title":"Mechanical prophylaxis, early mobilisation and risk stratification: as effective as drugs for low risk patients undergoing primary joint replacement. Results in 13,384 patients","volume":"18","author":"Gill","year":"2020","journal-title":"Surgeon"},{"key":"10.1016\/j.arth.2026.02.049_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty","volume":"378","author":"Anderson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arth.2026.02.049_bib14","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arth.2026.02.049_bib15","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2106\/JBJS.20.02250","article-title":"Venous thromboembolic prophylaxis after total hip and knee arthroplasty","volume":"103","author":"Lieberman","year":"2021","journal-title":"J Bone Jt Surg Am"},{"key":"10.1016\/j.arth.2026.02.049_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.artd.2020.12.025","article-title":"Hospital length of stay is associated with increased likelihood for venous thromboembolism after total joint arthroplasty","volume":"8","author":"Salomon","year":"2021","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.arth.2026.02.049_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"10.1016\/j.arth.2026.02.049_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jor.2025.05.018","article-title":"GLP-1 receptor agonist use in elective lumbar spine surgery: reduced pseudarthrosis rates and favorable safety profile","volume":"65","author":"Tummala","year":"2025","journal-title":"J Orthop"},{"key":"10.1016\/j.arth.2026.02.049_bib20","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.3390\/jcm13164920","article-title":"Usage of tranexamic acid for total hip arthroplasty: a matched cohort analysis of 144,344 patients","volume":"13","author":"Thapaliya","year":"2024","journal-title":"J Clin Med"},{"issue":"2 Suppl","key":"10.1016\/j.arth.2026.02.049_bib21","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arth.2026.02.049_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.arth.2016.02.077","article-title":"Individualized risk model for venous thromboembolism after total joint arthroplasty","volume":"31","author":"Parvizi","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2026.02.049_bib23","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.arth.2026.02.049_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-158-11-201306040-00004","article-title":"Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial","volume":"158","author":"Anderson","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arth.2026.02.049_bib25","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s11606-019-05122-3","article-title":"Aspirin compared with anticoagulation to prevent venous thromboembolism after knee or hip arthroplasty: a large retrospective cohort study","volume":"34","author":"Baumgartner","year":"2019","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.arth.2026.02.049_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.arth.2016.02.074","article-title":"Aspirin is as effective as and safer than warfarin for patients at higher risk of venous thromboembolism undergoing total joint arthroplasty","volume":"3","author":"Huang","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2026.02.049_bib28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2106\/JBJS.18.00335","article-title":"Potent anticoagulation does not reduce venous thromboembolism in high-risk patients","volume":"101","author":"Tan","year":"2019","journal-title":"J Bone Jt Surg Am"},{"key":"10.1016\/j.arth.2026.02.049_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.arth.2021.10.001","article-title":"Aspirin thromboprophylaxis is associated with less major bleeding events following total joint arthroplasty","volume":"37","author":"Shohat","year":"2022","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2026.02.049_bib31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2106\/JBJS.18.00143","article-title":"The use of aspirin for prophylaxis against venous thromboembolism decreases mortality following primary total joint arthroplasty","volume":"101","author":"Rondon","year":"2019","journal-title":"J Bone Jt Surg Am"},{"key":"10.1016\/j.arth.2026.02.049_bib27","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11999-017-5394-6","article-title":"Venous thromboembolism prophylaxis after TKA: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?","volume":"475","author":"Bala","year":"2017","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2026.02.049_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5435\/00124635-200903000-00007","article-title":"Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty","volume":"17","author":"Johanson","year":"2009","journal-title":"J Am Acad Orthop Surg"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540326001981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540326001981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:31:41Z","timestamp":1775129501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540326001981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":28,"alternative-id":["S0883540326001981"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2026.02.049","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Low-Dose Aspirin the Safest Prophylaxis for Venous Thromboembolism Following Primary Total Hip Arthroplasty?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2026.02.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}